Tempest Therapeutics Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Tempest Therapeutics Inc
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
/ 
Frequently asked questions
To buy Tempest Therapeutics Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Tempest Therapeutics Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Tempest Therapeutics Inc is TPST:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Tempest Therapeutics Inc has its primary listing on NASDAQ. You can trade Tempest Therapeutics Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Tempest Therapeutics Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Tempest Therapeutics Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Tempest Therapeutics Inc.